Norathyriol is primarily studied for its potential anti-cancer properties, particularly in inhibiting tumor growth and metastasis. It has shown activity against several cancer cell lines by inducing apoptosis and blocking cell cycle progression. Research also indicates norathyriol can suppress inflammatory pathways, making it a candidate for development in anti-inflammatory therapies. Additionally, it exhibits antioxidant effects, which may contribute to cellular protection against oxidative stress. Its ability to modulate key signaling pathways, such as NF-κB and MAPK, underpins many of its biological activities. Norathyriol is being explored as a lead compound for designing derivatives with improved pharmacological profiles in oncology and chronic inflammatory diseases.